11 min listen
Fenofibrate Pharmacology Podcast Episode 310
FromReal Life Pharmacology - Pharmacology Education for Health Care Professionals
Fenofibrate Pharmacology Podcast Episode 310
FromReal Life Pharmacology - Pharmacology Education for Health Care Professionals
ratings:
Length:
13 minutes
Released:
Jan 18, 2024
Format:
Podcast episode
Description
On this podcast episode, I discuss fenofibrate pharmacology, adverse effects, kinetics, drug interactions, and much more!
Fenofibrate is typically only used for hypertriglyceridemia. The primary risk of hypertriglyceridemia is pancreatitis so we treat these levels because of this risk.
LFTs elevation has been associated with fenofibrate use as well as myopathy. In the presence of myopathy, checking CPK may be considered.
Fenofibrate is a weak CYP2C9 inhibitor. Warfarin and phenytoin are two important medications that may be affected by the use of fenofibrate.
Fenofibrate is typically only used for hypertriglyceridemia. The primary risk of hypertriglyceridemia is pancreatitis so we treat these levels because of this risk.
LFTs elevation has been associated with fenofibrate use as well as myopathy. In the presence of myopathy, checking CPK may be considered.
Fenofibrate is a weak CYP2C9 inhibitor. Warfarin and phenytoin are two important medications that may be affected by the use of fenofibrate.
Released:
Jan 18, 2024
Format:
Podcast episode
Titles in the series (100)
Acetaminophen – RLP Episode 010: On this episode I discuss the basics with acetaminophen and which disease states and other medications to look out for when you have patients taking acetaminophen. Other items discussed on the podcast Mechanism of action Adverse effects by Real Life Pharmacology - Pharmacology Education for Health Care Professionals